|
QTRTD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2942999999831E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.189100E-04 |
| Normal-vs-Stage2 |
1.11759999998906E-06 |
| Normal-vs-Stage3 |
2.01169999999307E-05 |
| Normal-vs-Stage4 |
4.45150000000227E-05 |
| Stage1-vs-Stage2 |
2.728200E-02 |
| Stage1-vs-Stage3 |
8.559500E-02 |
| Stage1-vs-Stage4 |
1.143010E-01 |
| Stage2-vs-Stage3 |
4.518800E-01 |
| Stage2-vs-Stage4 |
5.025400E-01 |
| Stage3-vs-Stage4 |
9.552800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5362999999935E-06 |
| Normal-vs-AfricanAmerican |
8.828800E-04 |
| Normal-vs-Asian |
9.709000E-01 |
| Caucasian-vs-AfricanAmerican |
8.571000E-01 |
| Caucasian-vs-Asian |
9.014000E-02 |
| AfricanAmerican-vs-Asian |
1.493020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.72710000026599E-07 |
| Normal-vs-Female |
1.420640E-03 |
| Male-vs-Female |
6.835500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.318400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.431000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.02109999958289E-07 |
| Normal-vs-Age(81-100Yrs) |
1.33100000021535E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.184600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.150200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.076100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.644100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.398000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.089680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.682000E-01 |
| Normal-vs-Grade 2 |
7.960600E-04 |
| Normal-vs-Grade 3 |
1.87480000413132E-08 |
| Normal-vs-Grade 4 |
2.606300E-04 |
| Grade 1-vs-Grade 2 |
3.386800E-01 |
| Grade 1-vs-Grade 3 |
3.891900E-02 |
| Grade 1-vs-Grade 4 |
1.671800E-01 |
| Grade 2-vs-Grade 3 |
6.204600E-03 |
| Grade 2-vs-Grade 4 |
1.635650E-01 |
| Grade 3-vs-Grade 4 |
6.916600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.602590E-04 |
| Normal-vs-ccB subtype |
3.393100E-04 |
| ccA subtype-vs-ccB subtype |
7.961200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89750999999294E-05 |
| Normal-vs-N1 |
6.694200E-01 |
| N0-vs-N1 |
3.024000E-01 |
|
|
